Big pharma firms pushes for US action against India over patent worries

Thursday, February 6, 2014

An Indian government committee is reviewing patented drugs of foreign firms to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them to bring down costs, two senior government officials told Reuters.

The drugs that are part of the review process are used for treating cancer, diabetes, hepatitis and HIV, said the sources, declining to give details. No timeline has been given for completion of the review process.

Source: The Economic Times (link opens in a new window)

Categories
Health Care
Tags
global health, governance, pharmaceutical industry, pricing, profits